Recommendations
Eurofins Biomnis follows the International recommendations of the American Congress of Obstetricians and Gynecologists (ACOG) and the Society for Maternal–Fetal Medicine (SMFM) in relation to the indications for non-invasive prenatal screening for patients at risk.
Main recommendations
- Risk greater than 1/1000 according to maternal serum markers
- Mothers aged > 38 years for patients that did not benefit of the maternal serum markers assay
- History of pregnancy with foetal aneuploidies
- Relative is carrier of a Robertsonian translocation involving chromosome 13 or 21
- Pregnancy with twins
- 1st line screening
An invasive diagnostic procedure should be considered for ultrasound abnormalities.
Other indications
We therefore encourage you to directly contact Eurofins Biomnis at international@biomnis.com with any questions going beyond the above main recommendations.
